Radiation dose-response relationship (ERR/Gy) in the Life Span Study... | Download Scientific Diagram
![RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model | Radiation Oncology | Full Text RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-020-01723-z/MediaObjects/13014_2020_1723_Fig4_HTML.png)
RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model | Radiation Oncology | Full Text
![Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression - International Journal of Radiation Oncology, Biology, Physics Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2002002259/2007056792/gr1.jpg)
Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression - International Journal of Radiation Oncology, Biology, Physics
![Cancer risk from radiation: reduction of dose rate lowers mammary cancer more effectively for adult rats - National Institutes for Quantum Science and Technology Cancer risk from radiation: reduction of dose rate lowers mammary cancer more effectively for adult rats - National Institutes for Quantum Science and Technology](https://www.qst.go.jp/uploaded/image/12721.jpg)
Cancer risk from radiation: reduction of dose rate lowers mammary cancer more effectively for adult rats - National Institutes for Quantum Science and Technology
![Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome | Scientific Reports Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-53562-y/MediaObjects/41598_2019_53562_Fig1_HTML.png)
Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome | Scientific Reports
![Individualized Dose-Escalation of HDR Prostate Brachytherapy Implant to Decrease Required External Beam Radiation Dose: A Retrospective Feasibility Study - Advances in Radiation Oncology Individualized Dose-Escalation of HDR Prostate Brachytherapy Implant to Decrease Required External Beam Radiation Dose: A Retrospective Feasibility Study - Advances in Radiation Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/10b00c5d-3350-4dcf-987d-955ebc07c9d1/gr1_lrg.jpg)
Individualized Dose-Escalation of HDR Prostate Brachytherapy Implant to Decrease Required External Beam Radiation Dose: A Retrospective Feasibility Study - Advances in Radiation Oncology
![Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database - Annals of Oncology Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/75715a5d-0372-4b06-aa66-0a3a604a6f7f/gr1.jpg)
Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database - Annals of Oncology
![Cancers | Free Full-Text | Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111In)/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels Cancers | Free Full-Text | Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111In)/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels](https://www.mdpi.com/cancers/cancers-13-02828/article_deploy/html/images/cancers-13-02828-g001.png)
Cancers | Free Full-Text | Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111In)/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels
![Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial - European Urology Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5a5bd102-77a0-4ccd-8932-4f7ce042a0ee/gr1_lrg.jpg)
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial - European Urology
![Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction - Radiotherapy and Oncology Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b9a2e9be-2c8c-4d16-a86e-6d62facdf2f0/gr1.jpg)
Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction - Radiotherapy and Oncology
![Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial - Clinical and Translational Radiation Oncology Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial - Clinical and Translational Radiation Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/55d11f01-b661-4500-b30f-f3233afad9da/gr1_lrg.jpg)
Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial - Clinical and Translational Radiation Oncology
![Variation of 4 MV X-ray dose rate strongly impacts biological response both in vitro and in vivo | Scientific Reports Variation of 4 MV X-ray dose rate strongly impacts biological response both in vitro and in vivo | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-64067-4/MediaObjects/41598_2020_64067_Fig1_HTML.png)
Variation of 4 MV X-ray dose rate strongly impacts biological response both in vitro and in vivo | Scientific Reports
![Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer - International Journal of Radiation Oncology, Biology, Physics Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7d23e041-db4b-4b4e-bb5b-7ac432ee0551/gr1_lrg.jpg)
Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer - International Journal of Radiation Oncology, Biology, Physics
Mechanistic Modeling of Dose and Dose Rate Dependences of Radiation-Induced DNA Double Strand Break Rejoining Kinetics in Saccharomyces cerevisiae | PLOS ONE
![Late Complications of High-Dose (≥66 Gy) Thoracic Conformal Radiation Therapy in Combined Modality Trials in Unresectable Stage III Non-small Cell Lung Cancer - Journal of Thoracic Oncology Late Complications of High-Dose (≥66 Gy) Thoracic Conformal Radiation Therapy in Combined Modality Trials in Unresectable Stage III Non-small Cell Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040021330/2053563770/gr1.jpg)